The drug, called icotrokinra and developed together with Protagonist Therapeutics, is an oral peptide designed to tamp down ...

Johnson & Johnson’s latest prospective offering to the IL-23 psoriasis space—a Protagonist Therapeutics-partnered once-daily ...

Participants' psoriasis symptoms were assessed at regular ... and patients and gives patients the power to pursue treatment that best fits their needs and preferences." People of color have ...

Icotrokinra, formerly known as JNJ-2113, is an investigational oral peptide that blocks the interleukin (IL)-23 receptor, which plays a significant role in the pathogenesis of moderate to severe ...

Data reveal a strong association between non–high-density lipoprotein (non-HDL) cholesterol to HDL cholesterol ratio and ...

But it’s not clear what those levels should be or what the best way is to achieve such ... higher and for longer than D2. “Topical treatments for psoriasis often contain synthetic forms ...

Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The ...

The best at-home skincare ... shampoos and creams that treat psoriasis and dandruff, you’re more likely to find it at a ...

Fish and lean protein, fruits and vegetables, legumes, nuts and seeds, olive oil, small amounts of low-fat dairy, and whole ...

Research shows lifestyle changes like diet, exercise, and smoking cessation can assist with improving psoriasis outcomes and ...

Patients should also be informed about the potential for developing chronic plaque-type psoriasis. Education about diagnosis and treatment of streptococcal infection with antibiotics should be ...

Researchers conducted a nationwide cohort study using data from the Taiwan National Health Insurance database and the Taiwan ...